Assured Investment Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-282
Closed -$15K 1272
2018
Q3
$15K Buy
+282
New +$13.7K ﹤0.01% 1126
2018
Q2
Sell
-37,913
Closed -$1.74M 1282
2018
Q1
$1.74M Sell
37,913
-120,336
-76% -$5.98M 0.04% 381
2017
Q4
$7.48M Buy
158,249
+149,197
+1,648% +$7.32M 0.15% 150
2017
Q3
$438K Buy
9,052
+5,401
+148% +$269K 0.01% 508
2017
Q2
$183K Sell
3,651
-39,083
-91% -$1.78M ﹤0.01% 529
2017
Q1
$1.91M Buy
42,734
+29,264
+217% +$1.22M 0.04% 181
2016
Q4
$518K Buy
13,470
+1,659
+14% +$64.9K 0.01% 438
2016
Q3
$464K Buy
11,811
+6,903
+141% +$281K 0.01% 435
2016
Q2
$201K Sell
4,908
-13,557
-73% -$541K ﹤0.01% 497
2016
Q1
$755K Buy
18,465
+5,890
+47% +$218K 0.02% 245
2015
Q4
$459K Buy
12,575
+5,178
+70% +$198K 0.01% 317
2015
Q3
$267K Sell
7,397
-22,675
-75% -$872K ﹤0.01% 469
2015
Q2
$1.21M Buy
30,072
+26,205
+678% +$1.14M 0.02% 206
2015
Q1
$167K Buy
+3,867
New +$168K ﹤0.01% 463
2014
Q2
Sell
-152,165
Closed -$6.22M 242
2014
Q1
$6.22M Buy
+152,165
New +$5.79M 0.1% 152

Other funds holding ORCL

Assured Investment Management's ORCL Position: Q4 2018 in Review

Assured Investment Management sold out of Oracle (ORCL) in Q4 2018, closing a stake of 282 shares — an estimated $15K sold.

Assured Investment Management first reported a position in ORCL in Q1 2014 and held it in 15 quarters. The position peaked at $7.48M in Q4 2017. 1,770 funds tracked by Wall St. Rank hold ORCL as of Q4 2018.

  • Assured Investment Management reported no remaining Oracle position as of Q4 2018 after selling out during the quarter.
  • Assured Investment Management sold 282 Oracle shares in Q4 2018, an estimated $15K.
  • Assured Investment Management first reported a position in Oracle in Q1 2014 and held it in 15 quarters.
  • Assured Investment Management's Oracle position peaked at $7.48M in Q4 2017.
  • 1,770 funds tracked by Wall St. Rank held Oracle as of Q4 2018.

Based on Assured Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.